121 related articles for article (PubMed ID: 19925361)
1. Drug transporters and renal drug disposition in the newborn.
De Gregori S; De Gregori M; Ranzani GN; Borghesi A; Regazzi M; Stronati M
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():31-7. PubMed ID: 19925361
[TBL] [Abstract][Full Text] [Related]
2. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
3. Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors.
Kato Y; Watanabe C; Tsuji A
Eur J Pharm Sci; 2006 Apr; 27(5):487-500. PubMed ID: 16376527
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny and drug metabolism in newborns.
Dotta A; Chukhlantseva N
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
[TBL] [Abstract][Full Text] [Related]
5. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety.
Lu AY
Drug Metab Dispos; 1998 Dec; 26(12):1217-22. PubMed ID: 9860931
[TBL] [Abstract][Full Text] [Related]
6. Renal drug transport: a review.
Bendayan R
Pharmacotherapy; 1996; 16(6):971-85. PubMed ID: 8947968
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic implications of renal anionic drug transporters.
Masereeuw R; Russel FG
Pharmacol Ther; 2010 May; 126(2):200-16. PubMed ID: 20227439
[TBL] [Abstract][Full Text] [Related]
8. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
9. The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions.
Polli JW; Humphreys JE; Harmon KA; Castellino S; O'Mara MJ; Olson KL; John-Williams LS; Koch KM; Serabjit-Singh CJ
Drug Metab Dispos; 2008 Apr; 36(4):695-701. PubMed ID: 18216274
[TBL] [Abstract][Full Text] [Related]
10. Organic anion transporter (Slc22a) family members as mediators of toxicity.
Sweet DH
Toxicol Appl Pharmacol; 2005 May; 204(3):198-215. PubMed ID: 15845414
[TBL] [Abstract][Full Text] [Related]
11. Renal transporters in drug development.
Morrissey KM; Stocker SL; Wittwer MB; Xu L; Giacomini KM
Annu Rev Pharmacol Toxicol; 2013; 53():503-29. PubMed ID: 23140242
[TBL] [Abstract][Full Text] [Related]
12. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
13. Transporters and drug therapy: implications for drug disposition and disease.
Ho RH; Kim RB
Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
Soars MG; Webborn PJ; Riley RJ
Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
[TBL] [Abstract][Full Text] [Related]
15. Determinants of variability in clearance of exogenous compounds in neonates.
Allegaert K; Van Den Anker JN; Tayman C; De Hoon J
Verh K Acad Geneeskd Belg; 2009; 71(3):141-64. PubMed ID: 20088252
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
[TBL] [Abstract][Full Text] [Related]
17. Drug disposition during the perinatal period.
Heimann G
Int J Biol Res Pregnancy; 1981; 2(1):1-14. PubMed ID: 7341492
[TBL] [Abstract][Full Text] [Related]
18. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
Robertson EE; Rankin GO
Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.
Cressman AM; Petrovic V; Piquette-Miller M
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):69-89. PubMed ID: 22142160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
